Skip to main content

Table 1 Clinical characteristics of the cohort

From: Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores

Variables N = 78
On admission
 Age, years (SD) 62 ± 11
 Male sex, n (%) 65 (83)
 Body mass index, kg/m2 (IQR) 27 (25-30)
 Ischemia time, minutes (IQR) 173 (140-239)
 Current smoker, n (%) 24 (31)
 Hypertension, n (%) 18 (23)
 Dyslipidemia, n (%) 6 (8)
 Previous angina, n (%) 9 (12)
 Previous known diabetes mellitus, n (%) 2 (3)
Treatment on admission
 Aspirin, n (%) 5 (6)
 Beta-blocker, n (%) 6 (8)
 ACE/ARB, n (%) 7 (9)
 Statin 6 (8)
Treatment at discharge
 Aspirin, n (%) 77 (99)
 Clopidogrel, n (%) 78 (100)
 Beta-blocker, n (%) 77 (99)
 ACE/ARB, n (%) 44 (56)
 Statin, n (%) 76 (97)
  1. Data are presented as number of patients and percentage in brackets for dichotomous variables or median and interquartile range. ACE angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, IQR inter-quartile range